Search

Search Results
Results 3611 - 3620 of 6674 for Cancer pain
  • News - 6 Apr 2026
    A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects in men with prostate cancer, raising levels of a molecule tied to energy...
  • Drug - 30 Mar 2026
    Consumer Medicine Information (CMI) about Cladritab intended for persons living in Australia.
  • News - 27 Mar 2026
    Artificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support - and the more information included in AI prompting, the better its performance.
  • News - 27 Mar 2026
    In the months before his wedding, Queens resident Roberto Pineda Sanchez noticed persistent rectal bleeding, a dangerous symptom he almost ignored.
  • Drug - 26 Mar 2026
    Consumer Medicine Information (CMI) about Velsipity intended for persons living in Australia.
  • Drug - 16 Mar 2026
    Consumer Medicine Information (CMI) about Vyloy intended for persons living in Australia.
  • Drug - 5 Mar 2026
    Consumer Medicine Information (CMI) about Nextstellis intended for persons living in Australia.
  • Drug - 4 Mar 2026
    Consumer Medicine Information (CMI) about Eprex intended for persons living in Australia.
  • News - 2 Mar 2026
    The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also...
  • News - 25 Feb 2026
    Daily aspirin use does not offer a quick or reliable way to prevent bowel cancer in the general population and carries immediate risks of serious bleeding, a new Cochrane review finds.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.